AMS completed the acquisition of Raleigh Coatings for £22m.

AMS, the surgical and advanced woundcare specialist company, completed the acquisition of Raleigh Coatings, an independent woundcare and bio-diagnostics coatings business, for £22m. "We are delighted to add Raleigh to the Group. We have been looking for synergistic technologies that add value to our woundcare business and this acquisition strengthens our position and product offering in that sector significantly. Having outsourced silicone coating and perforation for some time, we are pleased to bring this capability in-house. Raleigh has also played an important part in improving the design of our LiquiBand® XL mesh which we see as an important part of our continued US growth strategy. Raleigh's expertise in other sectors such as bio-diagnostic strips also opens up further new commercial opportunities for the Group. We look forward to welcoming the Raleigh team to the Group to build on their commercial success and leverage their development pipeline," Chris Meredith, AMS CEO.